Recruiting studies: Moderate To Severe Chronic Obstructive Pulmonary Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Treatment of Chronic Obstructive Pulmonary Disease by Infusion of Allogenic Mesenchymal Stem Cells
Phase 2 · 2 location(s) · Meribank Biotech Co., Ltd. · NCT06491043 Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo
Phase N/A · 36 location(s) · AstraZeneca · NCT07069829 A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D
Phase 3 · 301 location(s) · AstraZeneca · NCT06883305 Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obstructive P
Phase 4 · 5 location(s) · AstraZeneca · NCT06531798 Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and T
Phase 3 · 159 location(s) · GlaxoSmithKline · NCT06961214 Respiratory and Cardiovascular Alterations in Patients With Chronic Obstructive Pulmonary Disease
Phase N/A · 1 location(s) · Lithuanian University of Health Sciences · NCT06072690 A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease
Phase 2 · 12 location(s) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06300320 A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmo
Phase 2/Phase 3 · 103 location(s) · Pfizer · NCT07363694 A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
Phase 2 · 4 location(s) · Windward Bio · NCT07646587 A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Phase 2 · 1 location(s) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · NCT07418736 A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D
Phase 3 · 268 location(s) · AstraZeneca · NCT06878261 Phase II Study of RC1416 Injection in COPD
Phase 2 · 42 location(s) · Nanjing RegeneCore Biotech Co., Ltd. · NCT07402551 Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and T
Phase 3 · 15 location(s) · GlaxoSmithKline · NCT06959095 A Clinical Study of Inhaled Nitric Oxide in Patients With Chronic Obstructive Pulmonary Disease
NA · 1 location(s) · Novlead Inc. · NCT07382258 A Clinical Study of Inhaled Nitric Oxide in Moderate-to-Severe Chronic Obstructive Pulmonary Disease
NA · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT05896800 A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
Phase 2 · 33 location(s) · Sanofi · NCT07116031 A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial of JKN2403 in COPD
Phase 2 · 1 location(s) · Joincare Pharmaceutical Group Industry Co., Ltd · NCT07351734 A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary
Phase 2 · 368 location(s) · AstraZeneca · NCT07082738 Evaluation of 611 in Chinese Adults Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Phase 3 · 4 location(s) · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · NCT07039669

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.